IRIS
POLLICINO, Teresa
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.684
EU - Europa 3.170
AS - Asia 2.383
SA - Sud America 944
AF - Africa 59
OC - Oceania 12
Continente sconosciuto - Info sul continente non disponibili 3
Totale 11.255
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.600
SG - Singapore 958
BR - Brasile 869
IE - Irlanda 779
CN - Cina 712
SE - Svezia 703
IT - Italia 418
HK - Hong Kong 346
DE - Germania 286
FI - Finlandia 186
UA - Ucraina 178
PL - Polonia 177
VN - Vietnam 115
RU - Federazione Russa 114
GB - Regno Unito 99
FR - Francia 87
IN - India 54
CA - Canada 36
BE - Belgio 33
MX - Messico 33
BD - Bangladesh 27
TR - Turchia 25
AR - Argentina 23
IQ - Iraq 23
ZA - Sudafrica 20
AT - Austria 19
CZ - Repubblica Ceca 19
ID - Indonesia 18
JP - Giappone 17
ES - Italia 16
NL - Olanda 16
PK - Pakistan 14
UZ - Uzbekistan 14
CO - Colombia 12
MA - Marocco 12
EC - Ecuador 11
NZ - Nuova Zelanda 8
PY - Paraguay 8
AE - Emirati Arabi Uniti 7
GR - Grecia 7
JO - Giordania 7
LT - Lituania 7
CI - Costa d'Avorio 6
KE - Kenya 6
AZ - Azerbaigian 5
KG - Kirghizistan 5
LB - Libano 5
NP - Nepal 5
PE - Perù 5
VE - Venezuela 5
AL - Albania 4
AU - Australia 4
BG - Bulgaria 4
BO - Bolivia 4
CL - Cile 4
HN - Honduras 4
IR - Iran 4
OM - Oman 4
AO - Angola 3
CH - Svizzera 3
EG - Egitto 3
PS - Palestinian Territory 3
SN - Senegal 3
UY - Uruguay 3
CR - Costa Rica 2
DO - Repubblica Dominicana 2
DZ - Algeria 2
EE - Estonia 2
EU - Europa 2
GT - Guatemala 2
IL - Israele 2
JM - Giamaica 2
LK - Sri Lanka 2
LV - Lettonia 2
MD - Moldavia 2
SV - El Salvador 2
AM - Armenia 1
BN - Brunei Darussalam 1
BW - Botswana 1
BY - Bielorussia 1
GE - Georgia 1
HR - Croazia 1
HU - Ungheria 1
KR - Corea 1
KZ - Kazakistan 1
LU - Lussemburgo 1
MY - Malesia 1
NG - Nigeria 1
NO - Norvegia 1
PA - Panama 1
PT - Portogallo 1
QA - Qatar 1
RO - Romania 1
RS - Serbia 1
SA - Arabia Saudita 1
SK - Slovacchia (Repubblica Slovacca) 1
TG - Togo 1
TH - Thailandia 1
TJ - Tagikistan 1
TM - Turkmenistan 1
Totale 11.253
Salva come PNG Salva come JPEG
Città #
Ashburn 791
Dublin 779
Dallas 714
Chandler 543
Singapore 490
Nyköping 408
Jacksonville 371
Hong Kong 346
Beijing 336
Messina 250
Warsaw 163
Los Angeles 133
Princeton 119
Ann Arbor 117
Munich 106
Medford 98
Cambridge 90
The Dalles 88
Des Moines 82
São Paulo 74
Boardman 63
New York 58
Dearborn 51
Moscow 50
Helsinki 47
Ho Chi Minh City 46
Houston 46
Buffalo 43
Jinan 41
Turku 40
Wilmington 36
Woodbridge 36
Brussels 32
Brasília 30
Belo Horizonte 29
Pune 27
Redondo Beach 27
San Mateo 27
Hanoi 23
Frankfurt am Main 22
Rio de Janeiro 22
Falls Church 21
Nanjing 21
Phoenix 18
Tianjin 18
Boston 17
Jakarta 17
Nuremberg 17
Zhengzhou 17
Brooklyn 16
Dong Ket 16
Stockholm 16
Tokyo 16
Rome 15
Shenyang 15
Rosolini 14
Santa Clara 14
Brno 13
Hebei 13
Porto Alegre 13
Tashkent 13
Atlanta 12
Chennai 12
Chicago 12
Johannesburg 12
Lappeenranta 12
Mexico City 12
San Francisco 12
Norwalk 11
Salvador 11
Seattle 11
Amsterdam 10
Düsseldorf 10
Guangzhou 10
London 10
Montreal 10
Baghdad 9
Fortaleza 9
Guarulhos 9
Haikou 9
Manchester 9
Catania 8
Curitiba 8
Denver 8
Dhaka 8
Goiânia 8
Ottawa 8
Tappahannock 8
Uberlândia 8
Columbus 7
Haiphong 7
Hangzhou 7
Ipatinga 7
Lahore 7
Nanchang 7
Osasco 7
Poplar 7
Praia Grande 7
Santo André 7
Vienna 7
Totale 7.567
Salva come PNG Salva come JPEG
Nome #
Impact of hepatitis B virus (HBV) preS/S genomic variability on HBV surface antigen and HBV DNA serum levels. 322
Analysis of haemochromatosis gene mutations in a population from the Mediterranean Basin. 205
Hepatitis B virus (HBV) DNA integration in patients with occult HBV infection and hepatocellular carcinoma. 185
PIVKA-II is a useful tool for diagnostic characterization of ultrasound-detected liver nodules in cirrhotic patients 185
Lack of the NS5B S282T mutation in HCV isolates from liver tissue of naive patients with HCV genotype-1b infection. 163
Free episomal and integrated HBV DNA In HBsAg-negative patients with intrahepatic cholangiocarcinoma 157
Risk Factors Associated with NASH in Obese Patients Undergoing Bariatric Surgery NASH and bariatric surgery 154
NS3 Variability in Hepatitis C Virus Genotype 1A Isolates from Liver Tissue and Serum Samples of Treatment-Naïve Patients with Chronic Hepatitis C 147
A combination of different diagnostic tools allows identification of inactive hepatitis B virus carriers at a single time point evaluation 139
Frequency of somatic mutations in TERT promoter, TP53 and CTNNB1 genes in patients with hepatocellular carcinoma from Southern Italy 137
Evaluation of CTNNB1 and TP53 variability in patients with hepatocellular carcinoma and occult hepatitis B virus infection 137
Analysis of occult hepatitis B virus infection in liver tissue of HIV patients with chronic hepatitis C. 136
Non-sequencing molecular approaches to identify preS2-defective hepatitis B virus variants proved to be associated with severe liver diseases 136
Control of cccDNA function in hepatitis B virus infection. 134
[A glance into the past ... Southern and northern blot: really superseded?] 134
Occult hepatitis B virus infection predicts non-alcoholic steatohepatitis in severely obese individuals from Italy 130
Is there a downgrading in the alert about the hepatitis B virus infection in Italy? 128
Behaviour of occult HBV infection in HCV-infected patients under treatment with direct-acting antivirals 127
Hepatitis B virus maintains its pro-oncogenic properties in the case of occult HBV infection 123
Clinical virology of hepatitis B virus infection 122
Cirrhosis related to wild-type HBV infection in siblings with A3 - B35 - Cw4 HLA class I phenotype. 122
A 2010 update on occult hepatitis B infection. 122
Hepatitis E virus infection as a cause of acute hepatitis in Southern Italy 121
AISF position paper on liver transplantation and pregnancy: Women in Hepatology Group, Italian Association for the Study of the Liver (AISF) 117
Flavocoxid exerts a potent antiviral effect against hepatitis B virus. 116
Both interferon alpha and lambda can reduce all intrahepatic HDV infection markers in HBV/HDV infected humanized mice 115
Human hepatitis B virus negatively impacts the protective immune cross-talk between natural killer and dendritic cells 115
Obesity and liver cancer 114
Occult hepatitis B virus infection is associated with the development of hepatocellular carcinoma in chronic hepatitis C patients. 114
Co-circulation of SARS-CoV-2 Alpha and Gamma variants in Italy, February and March 2021 114
Is investigation of hepatitis C virus NS5A gene heterogeneity a tool for predicting long-lasting response to interferon therapy in patients with HCV-1b chronic hepatitis? 111
Hepatitis B virus (HBV) induces the expression of interleukin-8 that in turn reduces HBV sensitivity to interferon-alpha. 111
INTRAHEPATIC HDV RNA, HBV DNA, AND HBV RNAS QUANTIFICATIONS REVEAL SUPPRESSION OF HBV PREGENOME RNA PRODUCTION WITH MAINTENANCE OF PRES/S TRNSCRITION IN HDV/HBV CO-INFECTED PATIENTS 110
Conserved transactivating and pro-apoptotic functions of hepadnaviral X protein in ortho- and avihepadnaviruses. 109
The characteristics of the cell-mediated immune response identify different profiles of occult hepatitis B virus infection. 109
Prevalence of hepatitis B and C viral infections in hospitalized patients with increased liver enzyme levels and with no known history of hepatic disease 108
Mitochondrial DNA is a target of HBV integration 107
Update of the statements on biology and clinical impact of occult hepatitis B virus infection 106
Hepatitis B e antigen detection in formalin-fixed liver biopsy specimens. A tool to investigate wild-type and E-minus variant HBV infection. 105
Disease progression and liver cancer in the ferroportin disease. 105
Hepatitis B Virus Replication Is Regulated by the Acetylation Status of Hepatitis B Virus cccDNA-Bound H3 and H4 Histones 104
Replicative and transcriptional activities of hepatitis B virus in patients coinfected with hepatitis B and hepatitis delta viruses. 104
Hepatitis B Virus Causes Epigenetic Induction of Interleukin-8Production which in Turn Inhibits Interferon-alfa Antiviral Activity 104
Targeting Hepatitis B virus infected cells with a T-cell receptor like antibody 102
Risk of occult hepatitis B virus infection reactivation in patients with solid tumours undergoing chemotherapy 101
HEPATITIS B VIRUS INDUCES INTERLEUKIN-8 N(IL-8) PRODUCTION IN HEPATOCYTES AND IL-8 IN TURN INHIBITS INERFERON ALFA ANTIVIRAL ACITIVITY 99
Divergent effects of interleukin-10 on cytokine production by mononuclear phagocytes and endothelial cells. 98
TT virus has a ubiquitous diffusion in human body tissues: analyses of paired serum and tissue samples. 98
Infection with HBV preS/S Variants is Highly Prevalent and Influences Amount of Circulating HBsAg Independently of Serum HBV DNA Levels and Response to Interferon Therapy in Chronic Hepatitis B 98
HEPATITIS B VIRUS INDUCES INTERLEUKIN-8 (IL8) PRODUCTION IN HEPATOCYTES AND IL-8 IN TURN INHIBITS INTERFERON ALFA ANTIVIRAL ACTIVITY 96
High prevalence of non-organ-specific autoantibodies in hepatitis C virus-infected cirrhotic patients from southern Italy. 95
Outcome of liver disease and response to interferon treatment are not influenced by hepatitis B virus core gene variability in children with chronic type B hepatitis. 95
Impact of Occult Hepatitis B Virus Infection on the Outcome of Chronic Hepatitis C. 95
Molecular analyses of TT virus in paired and tissue samples from 150 patients with either hepatic or non-hepatic disease 94
Analysis of HBV integration in mitochondrial DNA of HepAD38 cells by the high-throughput HBV integration sequencing and RNASeq approaches 92
Cutting Edge: Hyperinflammatory Monocytes Expressing CD56 Abound in Severe COVID-19 Patients 92
FULMINANT-HEPATITIS ASSOCIATED WITH THE INTRAFAMILIAR SPREAD OF A PRE-S2 DEFECTIVE HBV VARIANT AND THE LATE EMERGENCE OF HBEAG- MINUS VIRAL STRAINS 92
HEPATITIS B VIRUS INDUCES INTERLEUKIN-8 PRODUCTION WHICH IN TURN INHIBITS INTERFERON ALFA ANTIVIRAL ACTIVITY IN HEPATOMA CELL LINES 92
Virological profiles in hepatitis B virus inactive carriers: monthly evaluation in 1-year follow-up study 91
Occult hepatitis B virus in liver tissue of individuals without hepatic disease. 89
Ficolin-2 Plasma Level Assesses Liver Fibrosis in Non-Alcoholic Fatty Liver Disease 89
A roadmap for serum biomarkers for hepatitis B virus: current status and future outlook 88
Genomic heterogeneity of hepatitis B virus (HBV) and outcome of perinatal HBV infection. 88
PRE-S GENETIC VARIANTS ARE HIGHLY PREVALENT AND SIGNIFICANTLY CORRELATE WITH LOWER LEVELS OF HBSAG IN ACTIVE HBV INFECTIONS 87
NS3 genetic variability in hepatitis C virus genotype-1b isolates from liver specimens and blood samples of treatment naïve patients with chronic hepatitis C 87
Molecular and functional analysis of occult hepatitis B virus isolates from patients with hepatocellular carcinoma. 85
Variability of reverse transcriptase and overlapping S gene in hepatitis B virus isolates from untreated and lamivudine-resistant chronic hepatitis B patients. 85
Severe outcome of hepatitis B virus (HBV) infection and lack of HBV e antigen-defective virus emergence in patients homozygous for HLA class I alleles. 85
Neoangiogenesis-related genes are hallmarks of fast-growing hepatocellular carcinomas and worst survival. Results from a prospective study 85
NS3 Q80K Polymorphism in viral isolates from Liver Tissues and serum samples of naive HCV genotype 1a Patients 84
Pre-S2 defective hepatitis B virus infection in patients with fulminant hepatitis. 83
Proliferation of primary human hepatocytes and prevention of hepatitis B virus reinfection efficiently deplete nuclear cccDNA in vivo 83
Assessing Genomic Mutations in SARS-CoV-2: Potential Resistance to Antiviral Drugs in Viral Populations from Untreated COVID-19 Patients 82
Evaluation of hepatitis B and C virus infections in patients with non-Hodgkin's lymphoma and without liver disease 81
Hepatitis B virus DNA integration in tumour tissue of a non-cirrhotic HFE-haemochromatosis patient with hepatocellular carcinoma. 81
Hepatitis B virus PreS/S gene variants: Pathobiology and clinical implications. 81
Role of humoral immunity against hepatitis B virus core antigen in the pathogenesis of acute liver failure 80
Virological profiles in patients with chronic hepatitis C and overt or occult HBV infection. 79
Occult HBV infection 79
Occult hepatitis B virus infection 76
Statements from the Taormina expert meeting on occult hepatitis B virus infection. 76
Resistance analysis and treatment outcomes in hepatitis C virus genotype 3 infected patients within the Italian network VIRONET-C 76
Assessing immunological and virological responses in the liver: implications for the cure of chronic hepatitis B virus infection 75
Occult hepatitis B virus infection in patients with chronic hepatitis C liver disease 74
Pro-apoptotic effect of the hepatitis B virus X gene. 71
Transcriptional regulation of miR-224 upregulated in human HCCs by NFκB inflammatory pathways. 70
Quantification of intrahepatic hepatitis B virus (HBV) DNA in patients with chronic HBV infection. 70
Occult hepatitis B virus infection in hepatitis C virus negative chronic liver diseases 69
Occult hepatitis B virus and hepatocellular carcinoma. 68
What is the clinical impact of occult hepatitis B virus infection? 66
HBV-integration studies in the clinic: Role in the natural history of infection 66
The hepatitis B virus X protein abrogates Bcl-2-mediated protection against Fas apoptosis in the liver. 65
Hepatocellular carcinoma: the point of view of the hepatitis B virus. 65
Occult hepatitis B infection and hepatocellular carcinoma: Epidemiology, virology, hepatocarcinogenesis and clinical significance 65
Infection with hepatitis C virus depends on TACSTD2, a regulator of claudin-1 and occludin highly downregulated in hepatocellular carcinoma 64
Type II interleukin-1 receptor is not expressed in cultured endothelial cells and is not involved in endothelial cell activation. 63
Nuclear HBx binds the HBV minichromosome and modifies the epigenetic regulation of cccDNA function. 63
OCCULT HBV IS HIGHLY PREVALENT IN PATIENTS WITH INTRAHEPATIC CHOLANGIOCARCINOMA AND IT IS DETECTED AS BOTH FREE EPISOMAL AND INTEGRATED DNA 63
PreS and core gene heterogeneity in hepatitis B virus (HBV) genomes isolated from patients with long-lasting HBV chronic infection. 62
Heterogeneity of HBV genome. 62
Totale 10.304
Salva come PNG Salva come JPEG
Categoria #
all - tutte 43.703
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 43.703
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021466 0 0 0 0 0 83 39 96 44 103 51 50
2021/2022745 7 57 27 30 57 16 63 33 18 99 99 239
2022/20232.196 164 250 104 176 138 224 45 100 906 14 61 14
2023/2024719 50 111 26 61 41 103 2 228 3 23 20 51
2024/20252.658 47 19 80 227 115 121 137 519 554 150 228 461
2025/20262.957 360 649 611 546 700 91 0 0 0 0 0 0
Totale 11.471